nono-42
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 22, 2022 (NCT05636306)
Timeline
Indications
Studied for
Mechanism of action
- Disks large homolog 4INHIBITOR
DLG4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06403267 | Phase 2 | May 31, 2024 | NoNO Inc., University of Calgary |
| NCT05636306 | Phase 1 | Nov 22, 2022 | NoNO Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| NoNO Inc. | For profit | 2 | 2 | 2 | 2022 |
| University of Calgary | Academic/Hospital | 1 | 0 | 1 | 2024 |
2 organizations
Page 1 / 1